Clinical Trial Update: Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating immediate chemotherapy after surgical resection for high-risk non-muscle-invasive bladder cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Changhai Hospital | Conditions: NMIBC | NA | Status: RECRUITING